CHANGE: 2015 Brings Bumper Crop of New Rx Meds. “The science has got better and we seem to be finding more molecules that are showing material improvements. The old idea that industry pipelines are thin is not really true anymore. . . . Regulators are also getting much slicker at approving breakthrough drugs and in some cases the decisions are even coming faster than the companies expected.”